Abbott Laboratories And More On CNBC's 'Final Trades'

On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management named Innovator U.S. Equity Power Buffer ETF October (NYSE: POCT) as her final trade.

Stephen Weiss of Short Hills Capital Partners picked U.S. 10 Year Treasury Note .

Don’t forget to check out our premarket coverage here

Brenda Vingiello of Sand Hill Global Advisors named Abbott Laboratories (NYSE: ABT) as his final trade.

In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday. Abbott recently agreed to acquire Bigfoot Biomedical. However, financial terms of the deal were not disclosed.

Shannon Saccocia of Boston Private picked Vanguard Real Estate Index Fund (NYSE: VNQ).

Price Action: Abbott Laboratories shares gained 2.7% to close at $98.12 on Thursday.
Check This Out: Nike, Carnival And 3 Stocks To Watch Heading Into Friday